Vimarsana
Biggest News Aggregation in the World

Malaria Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Malaria Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Malaria Summit Today - Breaking & Trending Today

Bill Gates' highest form of praise to employees 'was to brutally insult them', ex-Microsoft manager claims - Vimarsana News

Bill Gates' highest form of praise to employees 'was to brutally insult them', ex-Microsoft manager claims

Scot Bayless, an ex-studio manager overseeing the team for the production of Flight Simulator 2000, said that Gates swore at staff when responding in disbelief to the level of detail in the game.

Novartis Renews Commitment To Neglected Tropical Disease And Malaria Elimination - Vimarsana News

Novartis Renews Commitment To Neglected Tropical Disease And Malaria Elimination

Investing USD 250 Million Over Five Years To Research And Develop New Treatments

Source: africa.com
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments - Vimarsana News

Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five years Commitment includes USD 100 million to advance R&D for Chagas disease, leishmaniasis, dengue and cryptosporidiosis, and USD 150 million for next-generation antimalarials

Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments - Vimarsana News

Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Novartis Pharma AG: Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments - Vimarsana News

Novartis Pharma AG: Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five yearsCommitment includes USD 100 million